CultHealth
CultHealth is a New York-based healthcare advertising agency serving pharmaceutical and biotechnology brands with direct-to-consumer and healthcare-professional campaigns across oncology, rare disease, hematology, and other therapeutic areas. Since 2022 it has operated as a subsidiary of Indegene, using a Creative Intelligence methodology that fuses creative work with data, AI, and analytics.
- Company typePrivate
- Founded2005
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CultHealth does
CultHealth is a New York-based healthcare advertising agency founded in 2005 that builds direct-to-consumer (DTC) and healthcare-professional (HCP) brand campaigns for pharmaceutical and biotechnology clients. Since its 2022 acquisition by Indegene, the agency has repositioned its core offering around a methodology called Creative Intelligence (CI), which combines creative development with Indegene's data, AI, and analytics capabilities to deliver personalized brand experiences across therapeutic areas including oncology, rare disease, hematology, women's health, respiratory, and CNS.
The agency's primary client segments are pharmaceutical brands (primary) and biotechnology companies (secondary), with the value proposition centered on creating brand narratives that connect with patients and healthcare professionals while satisfying pharmaceutical regulatory requirements. CultHealth does not sell a discrete software product; rather, CI is embedded across the service delivery model, spanning brand strategy, creative development, digital marketing, and analytics. The work is delivered by an 11-50 person New York-based team led by co-founder and CEO Jeff Rothstein, supported by a senior bench of SVPs across account, creative, digital, HR, and project management, plus an EVP of Experience and Technology.
CultHealth operates a professional services revenue model, generating income through project-based engagements, retainer arrangements, and creative service fees. Go-to-market is consultative and enterprise-grade, with direct engagement of pharmaceutical and biotech brand teams rather than distribution through intermediaries. Pricing is quote-based and not publicly disclosed. As a wholly-owned subsidiary of Indegene, CultHealth's commercial scale, geographic reach, and AI/data infrastructure are functionally extensions of its parent platform.
CultHealth firmographics
Firmographics- Name
- CultHealth
- Legal name
- CultHealth
- Website
- https://culthealth.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CultHealth is a New York-based healthcare advertising agency serving pharmaceutical and biotechnology brands with direct-to-consumer and healthcare-professional campaigns across oncology, rare disease, hematology, and other therapeutic areas. Since 2022 it has operated as a subsidiary of Indegene, using a Creative Intelligence methodology that fuses creative work with data, AI, and analytics.
- Ownership category
- akta.pro rank
Where CultHealth is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CultHealth business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Healthcare Advertising Services: Professional advertising and creative services for pharmaceutical brands including DTC and HCP campaigns. Revenue is generated through project-based engagements, retainer arrangements, and creative service fees for developing brand narratives, campaign materials, and strategic marketing content.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
CultHealth product offering
Product offeringCore offering
CultHealth is a healthcare advertising agency that develops brand strategy, creative campaigns, and digital marketing programs for pharmaceutical and biotechnology clients. Through its proprietary Creative Intelligence (CI) methodology, the firm fuses creative storytelling with data, AI, and analytics to deliver DTC and HCP advertising campaigns across multiple therapeutic areas including oncology, rare disease, hematology, women's health, respiratory, and CNS.
Product overview
CultHealth operates as a single unified healthcare advertising agency rather than a platform with modular products. In 2022, CultHealth joined Indegene, combining Cult's creative capabilities with Indegene's data, AI, and analytics infrastructure. The company's primary offering is Creative Intelligence (CI), a methodology embedded throughout their service delivery that fuses creativity with data insights and technological capabilities to ensure brand messages reach the right audiences at the right time across DTC and HCP channels.
Differentiator
Problem solved
Functional benefit
Products and services
- Creative Intelligence (CI) Creative Intelligence (CI) is CultHealth's proprietary methodology that fuses creative capabilities with data, AI, and analytics to deliver personalized brand experiences for healthcare audiences. CI integrates creativity, insights, and technological know-how into a unified approach, hardwired across all client engagements to ensure brand messages reach the right audience at the right time across DTC and HCP channels. It is targeted at pharmaceutical and biotechnology brands seeking data-driven, creative-led healthcare advertising campaigns.
Companies that use CultHealth
Customer profileSegments3 records
Ideal customer profiles2 records
CultHealth technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
CultHealth partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- IndegenecoreIn 2022, CultHealth joined Indegene in a strategic acquisition. The combination of CultHealth's creative expertise with Indegene's data, AI and analytics capabilities created the new standard of Creative Intelligence (CI). This partnership enables CultHealth to offer integrated creative and data-driven solutions to healthcare brands.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
CultHealth competitors and assessment
Company assessmentBroad incumbents
- Ogilvy Health: Part of WPP's healthcare network, Ogilvy Health is one of the largest global healthcare advertising agencies with full-service DTC and HCP capabilities across pharma and biotech. CultHealth competes directly for pharma brand assignments but operates at materially smaller scale; Eric Vollmuth (EVP, Director of Client Services at CultHealth) previously worked at Ogilvy, indicating a recognized talent and capability overlap.
- McCann Health: A global healthcare advertising and communications network within IPG, McCann Health operates across DTC, HCP and medical communications for major pharma clients. Eric Vollmuth previously worked at McCann. CultHealth targets the same pharma client set with a boutique creative-led value proposition, making McCann a directly comparable competitor with broader geographic and service-line coverage.
- Havas Health & You: Havas Health is a global healthcare and wellness communications network offering creative, medical, and digital services to pharma and biotech. As a holding-company-affiliated network, it competes for the same enterprise pharma clients CultHealth serves, but at much greater scale and geographic reach.
- Publicis Health: Publicis Health is a major healthcare advertising and communications network spanning DTC, HCP, and medical communications. It is one of the largest holders of pharma creative and media accounts globally and competes with CultHealth for the same pharma brand pitches, although with significantly broader capabilities and geographic coverage.
- Syneos Health Communications: Syneos Health offers commercial, medical affairs and advertising services to pharma and biotech, including a dedicated health communications group. CultHealth competes for overlap on biotech commercial-launch assignments, though Syneos operates at much larger scale and is integrated with clinical/contract resources.
Direct peers
- CDM (now CDM New York / CDM Worldwide): CDM is a long-standing healthcare-focused creative agency (David Stemler, CultHealth's CCO, previously held senior creative leadership at CDM New York earning a Gold at The Manny Awards). CultHealth and CDM compete for the same pharma AOR and brand assignments, with comparable DTC + HCP creative capabilities and similar boutique operating scale.
- The Bloc: The Bloc is a health-and-wellness creative agency known for award-winning pharma work; David Stemler, CultHealth's Chief Creative Officer, previously contributed to award-winning projects like 'Instant Doctor' at The Bloc. Both agencies compete for similar pharma/biotech creative engagements at boutique scale.
- FCB Health New York: FCB Health is one of the most-awarded healthcare creative networks and a direct competitor for pharma AOR, DTC, and HCP campaign work. CultHealth's small-team, creative-led positioning competes head-to-head with FCB Health in award circuits (Manny, One Show, Rx Awards) for the same pharma brand budgets.
- Intouch Group: Intouch Group is a healthcare-focused digital and creative agency that serves pharma brand teams across DTC, HCP and digital channels. CultHealth overlaps with Intouch on pharma digital and creative briefs, particularly for specialty therapeutic-area launches, and is similarly sized relative to Intouch's specialist creative pod.
- Calcium (Calcium+Company): Calcium+Company is a boutique health-and-wellness creative and communications agency competing for pharma and consumer health AOR work. CultHealth and Calcium compete directly for similar DTC/HCP mandates at comparable boutique scale and with overlapping therapeutic-area expertise.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
CultHealth social profiles
Digital presenceCultHealth financial estimates
Financial estimateRevenue estimate
Valuation estimate
CultHealth leadership team
Management profileNumber of profiles
Profiles17 records
CultHealth funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CultHealth M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CultHealth
What does CultHealth do?
CultHealth is a healthcare advertising agency that develops brand strategy, creative campaigns, and digital marketing programs for pharmaceutical and biotechnology clients. Through its proprietary Creative Intelligence (CI) methodology, the firm fuses creative storytelling with data, AI, and analytics to deliver DTC and HCP advertising campaigns across multiple therapeutic areas including oncology, rare disease, hematology, women's health, respiratory, and CNS.
Is CultHealth a public or private company?
CultHealth is a private company. It is classified as corporate owned and is currently operating.
When was CultHealth founded?
CultHealth was founded in 2005. It employs 11 to 50 people.
Where is CultHealth based?
CultHealth is headquartered in New York, United States, in the North America region.
How does CultHealth make money?
One revenue line is on record: healthcare Advertising Services.
Who are CultHealth's main competitors?
Broad incumbents on record are Ogilvy Health, McCann Health, Havas Health & You, Publicis Health and Syneos Health Communications. Direct peers are CDM (now CDM New York / CDM Worldwide), The Bloc, FCB Health New York, Intouch Group and Calcium (Calcium+Company).
Does CultHealth have an API?
No public API is recorded for CultHealth.